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Introduction
The maxilla and the mandible are the sites of  many 
cystic and neoplastic conditions which could be either 
benign or malignant.1 Swellings in the orofacial region 
are unique due to the obvious cosmetic defect and 
functional impairment of  the anatomically related aero-
digestive tract. Orofacial tumors are known to exhibit 
geographic variations in prevalence and pattern due to 
cultural, social, occupational or climatic factors as shown 
by studies from Nigeria 2,3, other African countries 4,5, 
Asia 6 and Western nations.7,8 Wakiaga et al.9 in a report 
from Kenya found ameloblastoma,Burkitt’s lymphoma, 
ossifying fibroma and osteogenic sarcoma as the most 
common tumors in that order. 
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In Nigeria, there are several reports of  oral and 
maxillofacial odontogenic and non-odontogenic 
tumors, odontogenic cysts and salivary gland tumors 
majority of  which have been from the northern and 
southwestern regions.  Arotiba et al.2 found that orofacial 
tumors constituted 20.2 % out of  a total of  342 patients 
seen over a period of  18 years in a study from Kano, 
Nigeria. The authors found squamous cell carcinoma 
and ameloblastoma as the most predominant orofacial 
tumors.  This was similar to the report from Ile-Ife 
southwest Nigeria, which also found ameloblastoma 
as the most predominant benign jaw tumor.3 In south-
south Nigeria, there is paucity of  epidemiological 
data on orofacial tumors. The only data that exist, to 
our knowledge, is that by Adebayo et al.10 from Port 
Harcourt.  The authors’ work was on spectrum of  oral 
and maxillofacial conditions and was not specifically for 
maxillofacial tumors and allied conditions. 
The aim of  this study was to determine the types, 
prevalence and demographic distribution of  maxillofacial 
tumors, cysts and tumor-like lesions in a tertiary health 
institution located in the South-South region of  Nigeria 
and to compare these data with previous reports. 
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Abstract
Background: This paper reviews the types, prevalence and demographic distribution of  maxillofacial tumors, cysts and 
tumor-like lesions in a Nigerian population.
Methods: A retrospective analysis of  the medical records and histological reports of  patients with oral and maxillofacial 
tumors and cystic lesions who presented to the Maxillofacial Unit of  our institution over an eleven year period was undertaken. 
Information on demographics, histological diagnosis and clinical presentation were obtained and analyzed. A p value of  less 
than 0.05 was considered significant.
Results: A total o:f  146 patients, aged 5-70 years (mean 30.5+ 12.9) were seen over the period of  study. There were 96 
males (65.8%) and 50 females (34.2%) giving a male to female ratio of  almost 2:1. Benign tumors accounted for 124, 
86.3% and malignant tumors (22, 13.7%). Ameloblastoma was the most prevalent benign tumor observed (53, 36.3%) while 
squamous cell carcinoma was the most common malignant tumor. The peak age of  ameloblastoma was the fourth decade 
and squamous cell carcinomas the sixth and seventh decades of  life. Jaw swellings were the most common presentation (98, 
67.1%), followed by pain (23, 15.9). The duration of  symptoms on presentation ranged from 1 to  96 months (mean 23.32 
+15.72) and this was not different for malignant or benign tumors (P=0.886).
Conclusion:Late presentation still remains the main challenging factor in the early detection and management of  maxillofacial 
tumors in our environment. More awareness campaign is necessary, especially at the primary health care level, to educate the 
populace on the need for early presentation at treatment centers.
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Methods
A retrospective analysis of  the medical records 
and histological reports of  patients with oral and 
maxillofacial tumors, cysts and tumor-like lesions 
who presented to the Maxillofacial Unit of  University 
of  Calabar Teaching Hospital from January 1997 to 
December 2007, a period of  11 years, was undertaken. 
Information on demographics, histological diagnosis 
and clinical presentation were obtained. The 2005 
WHO criteria 11 were adopted for the classification of  
odontogenic tumors and cyst of  the jaws. The age limit 
for categorizations of  tumor occurrence into pediatric 
or adult type was 19 years which is similar to that 
adopted by Aregbesola et al.3  The collected data were 
analyzed and a p value of  less than 0.05 was considered 
significant.
Results
A total of  146 patients, aged 5-70 years (mean 30.5+ 
12.9) were seen over the period of  study. There were 
96 males (65.8%) and 50 females (34.2%) giving a male 
to female ratio of  almost 2:1.There was no gender 
difference in terms of  age (p>0.05).  Benign tumors 
accounted for 124, 86.3% and malignant tumors (22, 
13.7%). Ameloblastoma was the most prevalent tumor 
observed 53 (36.3%) representing 80.3% of  the 66 
odontogenic tumors (OT).  The other OT included 
keratocystic odontogenic tumor 12 (8.2%) and 
adenomatoid odontogenic tumor 1 (0.7%). Other lesions 
include non-odontogenic tumors mainly represented by 
pyogenic granuloma 11 (7.5%) and giant cell granuloma 
4 (2.7%); fibro-osseous lesions 19 (13.0%),  jaw cysts 20 ( 
13.8%) and pleomorphic adenoma presenting as parotid 
swelling (1.4%). Malignant tumors comprised squamous 
cell carcinoma 8 (5.5%), Burkitt’s lymphoma 5(3.4%), 
osteogenic sarcoma 5(3.4%) and rhabdomyosarcoma 4 
(2.7%).
Table 1 shows the age distribution of  146 patients 
seen over 11 years in Calabar, Nigeria. The peak age 
of  ameloblastoma was the fourth decade while that of  
fibrous dysplasia and ossifying fibroma were the second 
and third decade respectively. The age distribution of  
malignant tumors between pediatric and adult population 
was significant (X2=457.33, df=108, p=0.001) (Table 
1). This shows that certain malignant tumors are age 
specific. Thus, childhood malignant conditions were 
observed to peak during the first decade and squamous 
cell carcinomas were seen in the sixth and seventh 
decades of  life (Table 1). 
Table 1. Age Distribution of  Oral and Maxillofacial Tumors and Tumor-like Lesions in 146 patients seen over 11 years 
Period
____________________________________________________________________________
Histological Types       1-10        11-20 21-30 31-40 41-50 51-60 61-70 Total %




Adenomatoid Odontogenic Tumor 0 0 1 0 0 0 0 1 0.7
Ameloblastoma   0 0 8 35 9 0 1 53 36.3
Keratocystic Odontogenic Tumor 0 4 5 3 0 0 0 12 8.2
Non-odontogenic Tumors
Giant Cell Granuloma  0 1 0 3 0 0 0 4 2.7
Pyogenic Granuloma  0 0 2 9 0 0 0 11 7.5
Osteoma   2 0 0 0 0 0 0 2 1.4
Fibro-osseous Lesions 
Fibrous Dysplasia   0 4 2 0 2 1 0 9 6.2
Osifying Fibroma   0 3 5 0 2 0 0 10 6.8
Cysts
Dentigerous Cyst   0 6 0 1 0 0 1 8 5.5
Radicular cyst   0 1 6 1 0 0 0 8 5.5
Nasoethmoidal Cyst  0 1 2 0 0 0 0 3 2.1
Globulomaxillary Cyst  0 0 1 0 0 0 0 1 0.7
Salivary gland tumors
Pleomorphic Adenoma  0 0 2 0 0 0 0 2 1.4
MALIGNANT TUMORS
Burkitt’s Lymphoma  5 0 0 0 0 0 0 5 3.4
Rhabdomyosarcoma  4 0 0 0 0 0 0 4 2.7
Osteogenic Sarcoma  0 0 4 1 0 0 0 5 3.4
Squamous Cell Carcinoma  0 0 0 0 0 5 3 8 5.5
Total    11 20 38 53 13 6 5 146 100
X2=457.33, df=108, p=0.001
_____________________________________________________________________________________________
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The gender distribution of  tumors and tumor-like 
lesions in 146 patients seen over the period of  study is 
shown in Table 2. Majority of  the maxillofacial tumors 
had predominant male distribution except for pyogenic 
granuloma, where female dominance was observed. The 
male to female ratios for benign and malignant tumors 
were 1:1.8 and 1:3.4 respectively (Table 2).
        58
Table 2. Gender distribution of  maxillofacial tumors and tumor-like lesions  in 146 patients seen over 11 years 
Period
_________________________________________________________
Histological Types             Female  Male  Total
                n (%)  n(%)  n(%)
_________________________________________________________
Benign Tumors
Adenomatoid Odontogenic Tumor 0(0.0)  1(0.7)  1(0.7)
Ameloblastoma   13(8.9)  40(27.4) 53(36.3)
Dentigerous Cyst   1(0.7)  7(4.8)  8(5.5)
Keratocystic Odontogenic Tumor 0(0.0)  12(8.2)  12(8.2)
Radicular cyst                6(4.1)  2(1.4)   8(5.5)
Nasoethmoidal Cyst               1(0.7)  2(1.4)  3(2.1)
Globulomaxillary Cyst               1(0.7)  0(0.0)  1(0.7)
Fibrous Dysplasia   5(3.4)  4(2.7)  9(6.1)
Osifying Fibroma   3(2.1)  7(4.8)  10(6.9)
Giant Cell Granuloma              0(0.0)  4(2.7)  4(2.7)
Pyogenic Granuloma              11(7.5)  0(0.0)  11(7.5)
Osteoma                2(1.4)  0(0.0)  2(1.4)
Pleomorphic Adenoma   2(1.4)  0(0.0)  2(1.4)
Malignant Tumors
Burkitt’s Lymphoma               1(0.7)  4(2.7)  5(3.4)
Rhabdomyosarcoma               0(0.0)  4(2.7)  4(2.7)
Osteogenic Sarcoma               0(0.0)  5(3.4)  5(3.4)
Squamous Cell Carcinoma  4(2.7)  4(2.7)  8(5.4)
Total                50 (34.3) 96(65.6)           146 (99.9)
X2=61.91, df=18, p=0.001
___________________________________________________________________
Table 3 shows the distribution of  lesions according to 
site and main presenting complaints in 146 patients seen 
over 11 years period. Overall the tumors were distributed 
in an approximate ratio of  3:1 between the mandible 
and maxilla. Among the benign lesions predilection 
for the mandible was observed for ameloblastoma, 
keratocystic odontogenic tumor, dentigerous cyst and 
ossifying fibroma in this series. There was an equitable 
distribution of  malignant tumors between mandible 
and maxilla with an approximate ratio of  1:1(Table 3). 
Across the series jaw swellings were the most common 
presentation (98, 67.1%), followed by pain (23, 15.9), 
toothache (12, 8.2%) and loose teeth (11, 7.5%) 
(Table 3). Half  of  the patients with malignant tumors 
presented with pain while only 9.7% of  patients with 
benign tumors presented with pain. Ulceration which is 
commonly seen in malignant lesions especially squamous 
cell carcinoma was not observed. The duration of  
symptoms on presentation ranged from 1 month to 96 
months (mean 23.32 +15.72) and this was not different 
for malignant or benign tumors (P=0.886).
Table 3. Distribution of  Maxillofacial Tumors and Tumor-like Lesions according to Site and Main 
Presenting complaints in 146 Patients   seen over 11 years Period
_______________________________________________________________________________________
______




Adenomatoid Odontogenic Tumor 0 0  1 0  0 1 (0.7)  
Ameloblastoma   0 53  0 0  0 53(36.3)  
Dentigerous Cysts   0 8  0 0  0 8 (5.5)  
Odontogenic  Keratocyst  0 12  0 0  0 12 (8.2) 
Radicular Cyst   0 3  5 0  0 8 (5.5)  
Nasoethmoidal  Cyst  0 0  3 0  0 3 (2.1)  
Globulomaxillary Cyst  0 0  1 0  0 1 (0.7) 
Fibrous dysplasia   0 0  9 0  0 9 (6.2)  
Ossifying fibroma   0 10  0 0  0 10 (6.8)               
Giant cell granuloma  0 3  1 0  0 4 (2.7)  
Pyogenic  granuloma  0 5  6 0  0 11 (7.5)                          
Osteoma    0 0  0 2  0 2 (1.4)  
Pleomorphic adenoma  0 0  0 0  2 2 (1.4)   
Burkitt’s  lymphoma  0 2  3 0  0 5 (3.4)  
Rhabdomyosarcoma  0 2  2 0  0 4 (2.7)  
Osteogenic  sarcoma  0 3  2 0  0 5 (3.4) 
Squamous  cell  carcinoma  1 4  3 0  0 8 (5.5)
Total     1 105  36 2  2 146 (100.0)
Presenting Complaints  Benign Lesions  Malignant  Lesions Total 
     n(%)   n (%)   n (%)
Displaced  Teeth  1(0.7)   0(0.0)   1(0.7)
Loose Teeth   8(5.5)   3(2.1)   11(7.5)
Missing Teeth   1(0.7)   0(0.0)   1(0.0)
Pain    12(8.2)   11(7.5)   23(15.9)
Swelling   94(64.4)  4(2.7)   98(67.1)
Toothache   8(5.5)   4(2.7)   12(8.2)
Total    124 (84.9)  22 (15.1)  146 (100.0)
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Discussion
The observed late presentation of  facial and intraoral 
swellings, often gross and disfiguring was similar to 
published reports.2,3  Benign lesions was the most 
common presentation (86.3%) while malignant lesions 
accounted for 13.7%. This sharply contrast previous 
reports from Nigeria and other parts of  the world 
where benign lesions were only slightly more than 
malignant lesions in their distribution. The reason for 
this difference may be explained by the exclusion of  
cystic and reactive lesions from the previous studies.2, 
12-14 Generally, studies from the developed countries 
reports higher proportion of  malignant jaw lesions than 
benign lesions when compared to reports from Africa. 
This observed difference may be explained in terms 
of  relatively lower life expectancy among Africans 
compared to their Western counterparts.15
Overall, ameloblastoma was the most predominant 
lesion (36.3%) and it accounted for 53 (80.3%) out 
of  the 66 odontogenic tumors (OT) observed in 
this series. The observed prevalence of  80.3%, while 
comparable to the 83.3% obtained by Adebiyi et 
al. from Lagos, Nigeria16 is much higher than results 
of  similar studies from Nigeria.2, 17, 18 Our observed 
prevalence of  ameloblastoma (n=53; 80.3%) in our 11 
year study period was comparable to that of  Adebayo 
et al.10 (n=12; 80%) recorded in a period of  5 years 
from the same geopolitical zone in southern Nigeria. 
One reason adduced for the relatively high frequency 
of  occurrence is the heterogeneous epithelial origin 
of  ameloblastoma. 19, 20 The relatively high prevalence 
obtained for ameloblastoma could also be due to 
“harvesting phenomenon” as defined by Anand et al.21 
Although the university of  Calabar teaching hospital 
has been in existence for over 3 decades, active oral and 
maxillofacial services commenced only a decade and a 
half  ago.  Our study period appears to coincide with 
the time when patients with orofacial tumors, including 
cystic lesions, were referred to our centre because of  
availability of  such services.   Apart from the suggested 
high predilection of  ameloblastoma for West Africans,22 
it is most likely that the relatively high prevalence of  
ameloblastoma observed in the present  study may 
also be due to the small size of  odontogenic tumors 
recorded among our study population. This assertion 
is strenghtened when our observed prevalence (80.3% 
out of  66 OT) is compared with those of  Arotiba et 
al 17(16% out of  415 OT), Ladeinde et al18 (63% out 
of  319 OT) and Odukoya 25 (58.5% out of  289 OT). 
The predilection for the mandible as well as the age 
and gender distribution is consistent with reports in the 
literature.16, 23, 24
In line with the recent WHO criteria 11 odontogenic 
keratocysts  categorized as odontogenic tumor 
(Keratocystic odontogenic tumor ( KCOT) was the 
next most common lesion (8.2%) after ameloblastoma 
across the series. This is contrary to the findings in 
some studies where KCOT were reported as the most 
prevalent OT in studies that used the 2005 WHO 
classification.25, 26 Expectedly, inclusion of  this cystic 
lesion as OT slightly (8.2%) increased the overall 
proportion of  OT in the series but it was much lower 
than the almost 50.0% increment observed by Servato 
et al. in a recent Brazilian study.26 
The prevalence of  odontogenic cysts has been shown 
to be in the range of  0.8-49.0%.22, 28, 29 We observed 
a prevalence of  11.0% in a period of  11 years.  Our 
relatively lower prevalence value obtained for 
odontogenic cyst in this study may be due to exclusion 
of  odontogenic keratocyst which was grouped under 
odontogenic tumor in the present analysis. Dentigerous 
and radicular cysts had peak age distribution of  second 
and third decade respectively. All the dentigerous cysts 
observed in this series occurred in the mandible while 
the maxilla was the predominant site of  occurrence for 
radicular cyst. The age and site distribution of  these 
cystic lesions was consistent with earlier reports.28, 30
Fibro-osseous lesions, distributed as fibrous dysplasia 
(6.2%) and ossifying fibroma (6.8%) collectively 
accounted for 13.0%.  Fibro-osseous lesions occurred 
over the second to the sixth decade with peak age of  
second and third decade for fibrous dysplasia and 
ossifying fibroma respectively. The often observed 
female predominance 31, 32 and predilection for the 
maxilla 31, 32 reported in the literature were not observed 
in the present study. The male to female ratio of  1:1.4 
obtained in the present study agreed with the result of  
an earlier study from Nigeria.33 There was no significant 
difference in terms of  occurrence in the mandible 10 
(6.8%) and maxilla 9 (6.2%) in this series.
Pyogenic granuloma is a relatively common tumor-like 
lesion which includes 3.81% to 7% of  all biopsy results 
of  oral cavity lesions.34, 35 The etiology of  pyogenic 
granuloma is unknown, but it has been linked to  trauma 
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due to chronic irritation from calculus, faulty appliances 
or restorations.35 The prevalence of  7.5% observed 
in the present study supports previous reports.34, 35 
Similarly, the age of  occurrence, female predominance 
and preference for the maxilla observed in this study 
lend credence to published reports.33, 34
Other less frequently observed benign lesions in the 
maxillofacial complex included giant cell granuloma, 
osteoma and pleomorphic adenoma presenting as 
parotid swelling. That only 2 (1.4%) cases of  salivary 
gland tumors were seen in the eleven year period of  
study was not surprising. In our institution various 
surgical subspecialties including general surgery, 
otorhinolaryngology and maxillofacial surgery are 
involved in the management of  salivary gland tumors 
especially those that involve the major glands. This 
probably explains the low prevalence of  salivary gland 
tumors observed in the present study.
The observed prevalence of  13.7% for malignant 
tumors while comparable to other reports 13, 36 is much 
lower than the 67.3% reported from East Africa by 
Kamulegeya and Kalmyanyama.14 The relatively lower 
figure for malignant tumors obtained in the present study 
and other similar studies may be due to inclusion of  
cysts and other tumor-like lesions in the data collection. 
Squamous cell carcinoma (5.5%), the most common 
malignant histological diagnosis constituted about 36.4% 
of  the malignant lesions in this series. This prevalence is 
lower than the 57.7% reported by Adekeye et al 15 from 
a review of  intraoral carcinomas in Northern Nigeria. 
This difference may be due to climatic differences. Our 
institution is within the rain forest belt of  Nigeria with 
lower levels of  sunshine compared to the dry savannah 
of  the northern part of  the country. This probably 
explains why lip cancer was not observed among our 
cases. Earlier studies from Nigeria observed frequent 
occurrences of  oral cancers in lower age groups.15, 37The 
observed peak age of  occurrence of   6th and 7th decades 
agreed with reports from the Western world.7,8 All the 
squamous cell carcinoma were observed in patients over 
50 years of  age.  The average life expectancy in Nigeria 
was previously estimated at 40 years.15 The result of  our 
study tends to lend credence to a recent World Health 
Statistics Report 38 that estimated the Nigerian life 
expectancy at birth for males as 47 years in 1990, 47 
years in 2000 and 53 years in 2009 and that of  females 
at 49 years in 1990, 48 years in 2000 and 54 years in 
2009.  The observed peak age of  occurrence could also 
be explained by the small size of  oral cancers (8) which 
were distributed within the 6th and 7th decades only.
Childhood malignant jaw tumors, represented by 
Burkitt’s lymphoma (3.4%)  and rhabdomyosarcoma 
(2.7%)  and  constituting 22.7% and 18.2% respectively 
of  all malignant lesions,  were observed to peak within 
the first decade of  life, which agreed with previous 
reports.39, 40 While the gender distribution of  Burkitt’s 
lymphoma is in support of   published reports,3,9 the 
observed slight predilection for the maxilla contrasts 
with other reports that noted higher occurrence in the 
mandible.3, 9, 14 The results of  this study support the 
observed female predominance for rhabdomyosarcoma 
5 but differs from that of  a  study from Germany.41 
Other malignant jaw tumors  such as Hodgkin and non-
Hodgkin lymphomas, malignant salivary gland tumors, 
neural and vascular lesions were not observed in this 
series. 
Conclusion
The epidemiology of  oral and maxillofacial tumors 
observed in this study, with the exception of  squamous 
cell carcinoma, is similar to previous reports from this 
part of  the globe. Our observed age of  occurrence 
of  squamous cell carcinoma is higher than previous 
reports from Nigeria. Late presentation still remains 
the main challenging factor in the early detection and 
management of  maxillofacial tumors. More awareness 
campaign is necessary, especially at the primary health 
care level, to educate the populace on the need for early 
presentation at treatment centers.
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